ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 609,15
0,00%
Dow Jones
39 127,80
0,04%
DAX
18 155,24
-0,04%
Brent Oil
84,37
-0,12%
Bitcoin
60 929,13
0,19%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Phoenix Biotech Aquisition Corporation (PBAXU)

  7. Phoenix Biotech Aquisition Corporation (PBAXU) Actualités

PBAXU

Phoenix Biotech Aquisition (PBAXU)

Phoenix Biotech Aquisition Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PBAXU
DateHeureSourceTitreSymboleSociété
05/06/202423h13Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
22/05/202414h00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
17/05/202423h09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
16/05/202412h28Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
06/05/202423h11Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
03/05/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
02/05/202406h16Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
01/05/202422h45Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
15/04/202422h36Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
03/04/202423h27Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
02/04/202413h12Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
02/04/202413h07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
02/04/202403h54Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
28/03/202402h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
27/02/202403h37Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
23/02/202423h13Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
20/02/202423h18Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
17/02/202401h29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
14/02/202418h14Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
22/01/202423h29Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
19/07/202314h33Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
03/07/202319h10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
07/06/202312h05Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
05/06/202315h27Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
12/05/202322h04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
24/03/202311h02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
14/02/202321h46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
14/02/202312h11Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
20/12/202222h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
21/11/202214h39Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:PBAXU

Dernières Valeurs Consultées

TG
A3LBZG
Bank of Valletta
USOTC
FMBM
F and M Bank (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés